Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 56.85%7.09B | -58.33%10.9B | -72.79%4.52B | 25.04%26.15B | 59.59%16.6B | 87.28%20.91B | 111.07%10.4B | 121.81%11.17B | 1,553.89%4.93B | 2,027.45%5.03B |
| Operating income | 56.85%7.09B | -58.33%10.9B | -72.79%4.52B | 25.04%26.15B | 59.59%16.6B | 87.28%20.91B | 111.07%10.4B | 121.81%11.17B | 1,553.89%4.93B | 2,027.45%5.03B |
| Cost of sales | -58.87%-7.12B | 58.05%-11.03B | 72.96%-4.48B | -28.28%-26.29B | -64.10%-16.59B | -85.00%-20.49B | -105.31%-10.11B | -121.04%-11.08B | -1,608.68%-4.92B | -2,129.85%-5.01B |
| Operating expenses | -58.87%-7.12B | 58.05%-11.03B | 72.96%-4.48B | -28.28%-26.29B | -64.10%-16.59B | -85.00%-20.49B | -105.31%-10.11B | -121.04%-11.08B | -1,608.68%-4.92B | -2,129.85%-5.01B |
| Gross profit | -217.88%-38.9M | 3.73%-131.8M | 121.48%33M | -132.49%-136.9M | -94.95%14.9M | 364.82%421.4M | 5,339.96%294.9M | 285.80%90.66M | -45.09%5.42M | 97.11%23.5M |
| Administrative expenses | 24.60%-46.9M | -0.74%-109.1M | -25.91%-62.2M | 17.27%-108.3M | 7.66%-49.4M | -19.16%-130.9M | -99.24%-53.5M | -177.09%-109.85M | -39.76%-26.85M | 24.12%-39.64M |
| Impairment and provision | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 99.74%-5.82M |
| -Other impairment is provision | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 99.74%-5.82M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | -234.19%-14.3M | -25.30%-13.93M | 23.41%-4.28M | 19.53%-11.12M |
| Special items of operating profit | -39.35%20.5M | 34.45%188.5M | -74.36%33.8M | 978.46%140.2M | 6,490.00%131.8M | -96.55%13M | -68.89%2M | 1,644.28%376.76M | 117.65%6.43M | -1,658.98%-24.4M |
| Operating profit | -1,519.57%-65.3M | 50.10%-52.4M | -95.27%4.6M | -134.60%-105M | -57.53%97.3M | -11.68%303.5M | 1,288.15%229.1M | 697.84%343.64M | 62.88%-19.28M | 97.51%-57.48M |
| Financing cost | 56.12%-8.6M | 39.74%-32.9M | 30.00%-19.6M | -96.40%-54.6M | ---28M | ---27.8M | ---- | ---- | ---- | ---- |
| Share of profit from joint venture company | ---- | ---900K | ---- | ---- | ---- | ---- | ---- | 99.93%-5K | 99.71%-4K | -47.95%-7.08M |
| Special items of earning before tax | 316.28%9.3M | ---- | ---4.3M | ---- | ---- | --25M | ---- | ---- | ---- | ---- |
| Earning before tax | -234.72%-64.6M | 45.99%-86.2M | -127.85%-19.3M | -153.08%-159.6M | -69.75%69.3M | -12.49%300.7M | 1,287.91%229.1M | 632.29%343.64M | 63.84%-19.29M | 97.21%-64.56M |
| Tax | 162.50%3.5M | -113.19%-1.2M | 50.88%-5.6M | 161.49%9.1M | 19.72%-11.4M | -3.98%-14.8M | -492.90%-14.2M | 4.71%-14.23M | -277.14%-2.4M | -173.77%-14.94M |
| After-tax profit from continuing operations | -145.38%-61.1M | 41.93%-87.4M | -143.01%-24.9M | -152.64%-150.5M | -73.06%57.9M | -13.21%285.9M | 1,091.19%214.9M | 514.37%329.4M | 58.30%-21.68M | 96.53%-79.49M |
| Earning after tax | -145.38%-61.1M | 41.93%-87.4M | -143.01%-24.9M | -152.64%-150.5M | -73.06%57.9M | -13.21%285.9M | 1,091.19%214.9M | 514.37%329.4M | 58.30%-21.68M | 96.53%-79.49M |
| Minority profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 118.18%2K | 126.67%4K | 78.43%-11K |
| Profit attributable to shareholders | -145.38%-61.1M | 41.93%-87.4M | -143.01%-24.9M | -152.64%-150.5M | -73.06%57.9M | -13.21%285.9M | 1,091.01%214.9M | 514.43%329.4M | 58.28%-21.69M | 96.53%-79.48M |
| Basic earnings per share | -150.00%-0.007 | 41.86%-0.01 | -142.42%-0.0028 | -152.76%-0.0172 | -73.06%0.0066 | -13.30%0.0326 | 1,080.00%0.0245 | 513.19%0.0376 | 57.63%-0.0025 | 96.52%-0.0091 |
| Diluted earnings per share | -150.00%-0.007 | 41.86%-0.01 | -142.42%-0.0028 | -152.76%-0.0172 | -73.06%0.0066 | -13.30%0.0326 | 1,080.00%0.0245 | 513.19%0.0376 | 57.63%-0.0025 | 96.52%-0.0091 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young Accounting Firm | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.